期刊文献+

高血压大鼠心脏钙调蛋白磷酸酶与核因子κBp65的表达 被引量:1

The Expression of Caldneurin and NFκBp65 in the Heart of the Hypertension Rats
下载PDF
导出
摘要 目的探讨钙调蛋白磷酸酶(caicineurin)、核因子κBp65(NFκBp65)在高血压心血管重构信号转导通路的作用。方法建立腹主动脉缩窄高血压大鼠模型,以尾动脉测压法观察大鼠血压变化,用免疫组织化学和形态计量学方法,观察calcineurin、NFκBp65在心脏原位蛋白表达和心脏重量及其系数的变化。结果与假手术组比较,高血压大鼠血压明显升高[(144.70±4.85)vs(110.00±4.00)mmHg,P<0.01;(151.40±14.86)vs(114.36±5.5)mmHg,P<0.01]、心脏重量及其系数显著增加[(1.87±0.07)vs(1.51±0.13)g,P<0.01,(0.43±0.02)vs(0.33±0.01)g/100g,P<0.01]、心脏重构,钙调蛋白磷酸酶与NFκBp65在心脏过表达,而且阳性表达面积和阳性表达面积百分比增大[(107380.36±9268.64)vs.(14537.64±12169.42)μm2,P<0.01;(54797.00±17483.46)vs(3501.43±2919.18)μm2,P<0.01]。结论calcineurin与NFκBp65过表达参与了腹主动脉缩窄性高血压心血管重构的发生。 Objectives To study the role of calcineurin and NFκBp65 in the signal pathway of the cardiovascular remodeling in the hypertension rats. Methods Using a rat model of hypertension induced by abdominal aortic banding, blood pressure was measured with a tail cuff after 2 or 4 weeks of operation. The heart weight and heart weight/body weight were measured, and expression of calcineurin or NFκBp65 was studied by using immunohistochemistry in the heart after 11 weeks of operation. Results The blood pressure was increased [(144.70±4.85) vs (110.00 ±4.00),P〈0.01] ; The heart weight or heart weight/body weight were increased [ ( 151.40 ± 14.86) vs ( 114.36 ± 5.5 ), P 〈 0.01 ; ( 1.87 ± 0.07) vs ( 1.51 ±0.13 ) ,P 〈 0.01 ; (0. 43 ± 0.02) vs (0.33 ± 0.01 ), P 〈 0. 01 ], the calcineurin and NFκBp65 protein was overexpression, at the same time, its area and area percentage were increased [ ( 107380. 36 ± 9268.64) vs ( 14537.64 ± 12169.42), P 〈 0.01 ; (54797.00 ± 17483.46) vs (3501.43 ± 2919.18 ), P 〈 0.01 )in the hypertension rats. Conclusion The overexpression of calcineurin and NFκBp65 was involved in the cardiovascular remodeling in the hypertension rats.
出处 《中国分子心脏病学杂志》 CAS 2005年第3期530-534,共5页 Molecular Cardiology of China
关键词 高血压 动物模型 心血管重构 钙调蛋白磷酸酶 核因子ΚBP65 Hypertension Animal model Cardiovascular remodeling Calcineurin NFκBp65
  • 相关文献

参考文献20

  • 1[1]Shimoyama M, Hayashi D, Takimoto E. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation,1999,100: 2449-54.
  • 2[2]Zou Y, Hiroi Y, Uozumi H. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation ,2001,104: 97-101.
  • 3[3]Wang Z, Kutschke W, Richardson KE. Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin. Circulation, 2001,104:1657-63.
  • 4[4]Wilkins B J, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun,2004, 322:1178-91.
  • 5[5]Fukudo M, Yano I, Masuda S. Distinct Inhibitory Effects of Tacrolimus and Cyclosporin A on Calcineurin Phosphatase Activity. J Pharmacol Exp Ther, 2004 Sep 21.
  • 6[6]Gillis AM, Kavanagh KM, Mathison HJ. Heart block in mice overexpressing calcineurin but not NF-AT3. Cardiovasc Res, 2004,64:488-95.
  • 7[7]Diedrichs H, Chi M, Boelck B. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur J Heart Fail, 2004, 6:3-9.
  • 8[8]Frantz S, Stoerk S, Ok S. Effect of chronic heart failure on nuclear factor kappa B in peripheral leukocytes. Am J Cardiol, 2004, 94:671-3.
  • 9[9]Wilkins B J, Dai YS, Bueno OF. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.Circ Res, 2004,94:110-8.
  • 10[10]Mano A, Tatsumi T, Shiraishi J. Aldosterone directly induces myocyte apoptosis through calcineurin dependent pathways. Circulation,2004,110:317-23.

同被引文献13

  • 1张鑫,杨永健.缬沙坦对压力负荷心肌肥大钙调神经磷酸酶(CaN)通路的作用[J].高血压杂志,2005,13(6):358-362. 被引量:7
  • 2Lindsey ML. MMP induction and inhibition in myocardial infarction[J].Heart Fail Rev,2004,9:7-19.
  • 3Cha TJ, Ehrlich JR, Zhang L. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure[J].Circulation,2004,109:412-418.
  • 4Eugene Braunwald. Congestive heart failure: fifty years of progresss[J].Circ,2000,11:14-23.
  • 5Aquila-Pastir LA, DiPaola NR, Matteo RG. Quantitation and distribution of β-tubulin in human cardiac myocytes[J].J Mol Cell Cardiol,2002,34:1513-1523.
  • 6Belmadani S, Pous C, Ventura-Clapier R. Post-translational modifications of cardiac tubulin during chronic heart failure in the rat[J].Mol Cell Biochem,2002,237:39-46.
  • 7Heling A, Zimmermann R, Kostin S. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium[J].Circ Res,2000,86:846-853.
  • 8Hein S, Kostin S, Heling Α, et al. The role of the cytoskeleton in heart failure[J].Cardiovasc Res,2000,45:273-278.
  • 9Belmadani S, Pous C, Fischmeister R. Post-translational modifications of tubulin and microtubule stability in adult rat ventricular myocytes and immortalized HL-1 cardiomyocytes[J].Mol Cell Biochem,2004,258:35-48.
  • 10Roos KP, Palmer RE, Miller TW.The role of microtubules in structural remodeling and the progression to heart failure[J].J Card Fail,2002 ,8:S300-310.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部